Imago BioSciences Current Assets

Imago BioSciences (IMGO) currently reports a current assets of $180M as of September 2022. That compares with $230M in the prior-year period — down 22.4% year over year. Use the charts on this page to explore Imago BioSciences's current assets history and peer comparisons.

Imago BioSciences's current assets decreased from $230M to $180M — a 22.4% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Imago BioSciences reported $180M in current assets as of September 2022. That compares with $230M in the prior-year period — down 22.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Imago BioSciences, and consider following IMGO for alerts when major investors trade the stock.

Imago BioSciences is classified in the Healthcare sector. On current assets, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMGO with unrelated industries.